Clinical Trial Update: Phase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Clinical trial update describing a Phase 1 study of HS-20093 in combination regimens for extensive-stage small cell lung cancer; the study is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• HS-20093

Snippet

Sponsor: Shanghai Hansoh Biomedical Co., Ltd | Conditions: Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Phase 1 | Status: NOT_YET_RECRUITING